The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) PFGE strain type USA300 (multilocus sequence type 8, clonal complex 8, staphylococcal cassette chromosome mec type IV) was first reported in the USA as a cause of skin and soft issue infection among college football players in Pennsylvania and among prisoners in Missouri in 2000. Over the next 5 years, USA300 became the predominant community-associated MRSA strain in the USA. It was the most common PFGE type recovered from skin and soft tissue infections in persons presenting to 11 emergency departments across the USA, and caused outbreaks in Native American populations, children in daycare centres, military recruits, prison inmates and among men who have sex with men. Although predominantly a cause of skin and soft issue infection, USA300 isolates also have been recovered from cases of invasive disease including bacteraemia, endocarditis, severe necrotizing pneumonia and osteomyelitis. Isolates of USA300 usually carry the genes encoding the Panton-Valentine leucocidin and the arginine catabolic mobile element, but rarely carry staphylococcal enterotoxin genes. USA300 isolates are becoming more resistant to antimicrobial agents, including erythromycin, levofloxacin, mupirocin and tetracycline, and have spread to Europe, South America and Australia. The emergence of the MRSA USA300 strain type represents a unique biological success story.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122108599 · Cited by 1,588
Harmsen, D., Claus, H., Witte, W., Rothgänger, J., Claus, H., Turnwald, D., & Vogel, U. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5442-5448.2003 · Cited by 1,578
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationShopsin, B., Gomez, M., Montgomery, S. O., Smith, D. H., Waddington, M., Dodge, D. E., Bost, D. A., Riehman, M., Naidich, S., & Kreiswirth, B. N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3556-3563.1999 · Cited by 984
Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community
Okuma, K., Iwakawa, K., Turnidge, J. D., Grubb, W. B., Bell, J. M., O'Brien, F. G., Coombs, G. W., Pearman, J. W., Tenover, F. C., Kapi, M., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4289-4294.2002 · Cited by 888
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Self-citation
Cited by
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Authority, E. F. S., & European Centre for Disease Prevention and Control (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6490 · Cited by 874
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.41.19688-en · Cited by 611
Dermal adipocytes protect against invasive Staphylococcus aureus skin infection
Zhang, L.-J., Guerrero-Juarez, C. F., Hata, T., Bapat, S. P., Ramos, R., Plikus, M. V., & Gallo, R. L. (2015) · Science · doi:10.1126/science.1260972 · Cited by 471
Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)
Mediavilla, J. R., Chen, L., Mathema, B., & Kreiswirth, B. N. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.08.003 · Cited by 397
Song, J.-H., Hsueh, P.-R., Chung, D. R., Ko, K. S., Kang, C.-I., Peck, K. R., Yeom, J.-S., Kim, S.-W., Chang, H.-H., Kim, Y.-S., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr024 · Cited by 389
Authority, E. F. S., & European Centre for Disease Prevention and Control (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5182 · Cited by 384
A Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance
Martin, J. K., Sheehan, J. P., Bratton, B. P., Moore, G. M., Mateus, A., Li, S. H.-J., Kim, H., Rabinowitz, J. D., Typas, A., Savitski, M. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.005 · Cited by 356
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Authority, E. F. S., & European Centre for Disease Prevention and Control (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6007 · Cited by 332
Authority, E. F. S., & European Centre for Disease Prevention and Control (2019) · EFSA Journal · doi:10.2903/j.efsa.2019.5598 · Cited by 300
Kong, E. F., Tsui, C., Kucharíková, S., Andes, D., Van Dijck, P., & Jabra-Rizk, M. A. (2016) · mBio · doi:10.1128/mbio.01365-16 · Cited by 294
Application of Whole-Genome Sequencing for Bacterial Strain Typing in Molecular Epidemiology
Salipante, S. J., SenGupta, D. J., Cummings, L. A., Land, T. A., Hoogestraat, D. R., & Cookson, B. T. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-14 · Cited by 290
Pantosti, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00127 · Cited by 239
Lipinska, U., Hermans, K., Meulemans, L., Dumitrescu, O., Badiou, C., Duchateau, L., Haesebrouck, F., Etienne, J., & Lina, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022864 · Cited by 100
Murray, R. J., Robinson, J. O., White, J. N., Hughes, F., Coombs, G. W., Pearson, J. C., Tan, H.-L., Chidlow, G., Williams, S., Christiansen, K. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008705 · Cited by 84
Carroll, R. K., Weiss, A., Broach, W. H., Wiemels, R. E., Mogen, A. B., Rice, K. C., & Shaw, L. N. (2016) · mBio · doi:10.1128/mbio.01990-15 · Cited by 76
Aung, M., San, T., Aye, M., Mya, S., Maw, W., Zan, K., Htut, W., Kawaguchiya, M., Urushibara, N., & Kobayashi, N. (2017) · Toxins · doi:10.3390/toxins9080241 · Cited by 72
Major, T. A., Panmanee, W., Mortensen, J. E., Gray, L. D., Hoglen, N., & Hassett, D. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00379-10 · Cited by 61
O'Hara, F. P., Amrine-Madsen, H., Mera, R. M., Brown, M. L., Close, N. M., Suaya, J. A., & Acosta, C. J. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0056 · Cited by 45
“4,27,28 While the USA300 clone is named after a pulsed-field type, subsequent trends in molecular typing have allowed researchers to identify this clone using alternative methods.”
Metadata
- Authors
- Tenover, F. C., & Goering, R. V.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-16
- Volume
- 64
- Issue
- 3
- Pages
- 441-446
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2115771487
- Cited by
- 441
- References
- 43
- FWCI
- 22.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.